CRIPTO3 and myotonic dystrophy type 2: This led us to suspect that DM2 patients have alterations in complement that impair M. tuberculosis binding and phagocytosis by monocytes: the defect could be in DM2 monocyte receptors (CR1, CR3) and/or their serum ligands (C3b, iC3b).